Ynno Med
PrivateLast Round
Grant
Apr 1, 2025
Total Funding Raised
$1.13M
Company Overview
Ynno Med is a biotech company that has developed a drug R&D platform dedicated to addressing antimicrobial resistance by discovering and developing new antimicrobial agents.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ynno Med Comps
Public and private peers based on sector, stage, and business model.
Ynno Med Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2025 | ||||
| Corporate Funding | Oct 1, 2024 | ||||
| Grant | Apr 1, 2024 | ||||
| Grant | Apr 1, 2023 | ||||
| Grant | Apr 1, 2022 |
Ynno Med Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
$115K grant from Innovation and Technology Commission.
- Oct 1, 2024
Raised $192K in corporate funding.
Ynno Med Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ynno Med's valuation, stock price, and market status.
